Our medical staff consists of licensed and experienced nurses
The study involved participants with type 2 diabetes who were on metformin with or without an SGLT2 inhibitor
People are aging faster, getting sick more, and generally not energetic and happy
Stephen O'Rahilly - beneficios riesgos GLP1 Stephen O'Rahilly Profesor de Bioqumica Clnica y Medicina y director del Instituto Wellcome-MRC de Ciencia Metablica-Laboratorios de Investigacin Metablica de la Universidad de Cambridge (Reino Unido) Los estudios como este deben interpretarse con mucha cautela, ya que las personas estudiadas no han sido asignadas aleatoriamente al tratamiento con agonistas del receptor GLP-1, por lo que cualquier diferencia entre quienes toman y no toman esta clase de medicamentos podra ser atribuible a factores distintos al frmaco
Three key dimensions are central to the analysis: governance innovation, community empowerment, and cocreation of adaptive infrastructure.Key findings suggest that transformative planning can orchestrate different actors, integrate sustainability in decision-making processes, and facilitate fair resource distribution
